Shorter duration therapy that includes vincristine (V), dactinomycin (A), and lower doses of cyclophosphamide (C) with or without radiation therapy for patients with newly diagnosed low-risk embryonal rhabdomyosarcoma (ERMS): A report from the Children's Oncology Group (COG).
暂无分享,去创建一个
J. Meza | A. Pappo | D. Hawkins | W. Meyer | J. Breneman | T. Cripe | D. Parham | A. Hayes-Jordan | D. Walterhouse